Special Diabetes Program Reauthorization Act of 2025

This bill reauthorizes federal funding for diabetes programs targeting Type 1 diabetes. It extends annual funding of $160 million for fiscal years 2026 through 2030, continuing existing support for research, treatment, and prevention initiatives. The funds remain available until expended, directly supporting programs serving people with Type 1 diabetes and the organizations delivering these services. The bill makes no changes to program eligibility or structure, only extending current funding levels.